WIJKSTROM JOAKIM 1785888 Data last updated 2024-05-15 07:34:05 -0500 US CDT

Latest Holdings

Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.


Non-derivative Transactions     CSV download

Tips: type "code_s" to show transactions with code "S".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2023-08-23 2023-08-21 2023-08-21 4 Wijkstrom Joakim SVP, CHIEF MARKETING OFFICER dsp 3724.0 3.17 0.65 5.84 Direct Common Stock VANDA PHARMACEUTICALS INC.

code_S

code  S
113816.0 57.51 (VNDA)
2024-02-21 2024-02-16 2024-02-16 4 Wijkstrom Joakim SVP, CHIEF MARKETING OFFICER acq 32700.0 22.32 5.68 0.0 Direct Common Stock VANDA PHARMACEUTICALS INC.

code_A

code  A
146516.0 57.54 (VNDA)
2024-03-06 2024-03-04 2024-03-04 to 2024-03-05 4 Wijkstrom Joakim SVP, CHIEF MARKETING OFFICER dsp 16727.0 11.42 2.91 4.3 Direct Common Stock VANDA PHARMACEUTICALS INC.

code_S

code  S
129789.0 thumbnail 57.54 (VNDA)

Derivative Transactions

Tips: type "code_m" to show transactions with code "M".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e

a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)